Literature DB >> 15383570

DNA methylation is a nonredundant repressor of the Th2 effector program.

Karen W Makar1, Christopher B Wilson.   

Abstract

The extent to which DNA methylation contributes to proper regulation of murine T cell effector function is unclear. In this study, we show that in the absence of the maintenance DNA methyltransferase Dnmt1, silencing of IL-4, IL-5, IL-13, and IL-10 in CD8 T cells was abolished, and expression of these Th2 cytokines increased as much as 1000-fold compared with that of control CD8 T cells. Th2 cytokine expression also increased in Dnmt1(-/-) CD4 T cells, but the increase ( approximately 20-40-fold for IL-4 and IL-10, </=5-fold for IL-5 and IL-13) was less than for CD8 T cells. As a result, both Dnmt1(-/-) CD4 and CD8 T cells expressed high and comparable amounts of Th2 cytokines. Loss of Dnmt1 had more subtle effects on IL-2 (</=5-fold increase) and IFN-gamma ( approximately 5-10-fold increase) expression and did not affect the normal bias for greater IL-2 expression by CD4 T cells and greater IFN-gamma expression by CD8 T cells, nor the exclusive expression of perforin and granzyme B by the CD8 T cells. These results indicate that Dnmt1 and DNA methylation are necessary to prevent cell autonomous Th2 cytokine expression in CD8 T cells but are not essential for maintaining proper T cell subset-specific expression of Th1 or CTL effectors. We also found that the expression of Th2 cytokines by Dnmt1(-/-) T cells was appropriately up-regulated in Th2 conditions and down-regulated in Th1 conditions, indicating that transcription factors and DNA methylation are complementary and nonredundant mechanisms by which the Th2 effector program is regulated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15383570     DOI: 10.4049/jimmunol.173.7.4402

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  54 in total

1.  Murine neonatal CD4+ cells are poised for rapid Th2 effector-like function.

Authors:  Shawn Rose; Mathias Lichtenheld; Monica R Foote; Becky Adkins
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

Review 2.  Epigenetics of multiple sclerosis: an updated review.

Authors:  Cem İsmail Küçükali; Murat Kürtüncü; Arzu Çoban; Merve Çebi; Erdem Tüzün
Journal:  Neuromolecular Med       Date:  2014-03-21       Impact factor: 3.843

Review 3.  Regulation of CD4 T-cell differentiation and inflammation by repressive histone methylation.

Authors:  Frann Antignano; Colby Zaph
Journal:  Immunol Cell Biol       Date:  2015-01-13       Impact factor: 5.126

Review 4.  Roles of repressive epigenetic machinery in lineage decision of T cells.

Authors:  Taku Naito; Ichiro Taniuchi
Journal:  Immunology       Date:  2013-06       Impact factor: 7.397

Review 5.  T-cell memory differentiation: insights from transcriptional signatures and epigenetics.

Authors:  Ben Youngblood; J Scott Hale; Rafi Ahmed
Journal:  Immunology       Date:  2013-07       Impact factor: 7.397

Review 6.  DNA methylation: roles in mammalian development.

Authors:  Zachary D Smith; Alexander Meissner
Journal:  Nat Rev Genet       Date:  2013-02-12       Impact factor: 53.242

Review 7.  Epigenetic mechanisms underlying cardiac degeneration and regeneration.

Authors:  Pankaj Chaturvedi; Suresh C Tyagi
Journal:  Int J Cardiol       Date:  2014-02-20       Impact factor: 4.164

Review 8.  Cell type-specific regulation of IL-10 expression in inflammation and disease.

Authors:  Christian M Hedrich; Jay H Bream
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

Review 9.  The role of redox signaling in epigenetics and cardiovascular disease.

Authors:  Gene H Kim; John J Ryan; Stephen L Archer
Journal:  Antioxid Redox Signal       Date:  2013-03-12       Impact factor: 8.401

10.  Identification of DNA methyltransferase 3a as a T cell receptor-induced regulator of Th1 and Th2 differentiation.

Authors:  Christopher J Gamper; Agoston T Agoston; William G Nelson; Jonathan D Powell
Journal:  J Immunol       Date:  2009-07-22       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.